Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications

NCT01552434 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01552434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01552434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Terminated
Start date
October 16, 2012
Completion date
May 8, 2026
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant neoplasm, castleman disease, digestive system carcinoma, erdheim-chester disease, lip and oral cavity carcinoma, lymphangioleiomyomatosis, malignant endocrine neoplasm, malignant female reproductive system neoplasm, malignant male reproductive system neoplasm, malignant neoplasm, malignant respiratory tract neoplasm, malignant thoracic neoplasm, malignant urinary system neoplasm, mesothelial neoplasm, metastatic malignant neoplasm, metastatic urothelial carcinoma, neurofibromatosis type 2, recurrent adult soft tissue sarcoma, recurrent breast carcinoma, recurrent childhood soft tissue sarcoma, recurrent digestive system carcinoma, recurrent female reproductive system carcinoma, recurrent male reproductive system carcinoma, recurrent malignant neoplasm, recurrent pharyngeal carcinoma, recurrent thyroid gland carcinoma, refractory malignant neoplasm, soft tissue neoplasm, stage iii breast cancer ajcc v7, stage iii pharyngeal cancer, stage iiia breast cancer ajcc v7, stage iiib breast cancer ajcc v7, stage iiic breast cancer ajcc v7, stage iv breast cancer ajcc v6 and v7, stage iv pharyngeal cancer, stage iva pharyngeal cancer, stage ivb pharyngeal cancer, stage ivc pharyngeal cancer, thyroid gland neoplasm